← 홈

위암

121개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 121개
ADCBiologicDaiichi SankyoDM1) and trastuzumab deruxt…Phase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Trastuzmab deruxtecan)

Gastric Cancer; Gastroesophageal Junction (GEJ) Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 71.7%임상시험 56상태 RECRUITING
ADCBiologicAstraZenecaSN-38Phase 2

Nanoliposomal Irinotecan (Nanoliposomal Irinotecan)

Biliary Tract Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 7.7%임상시험 55상태 ACTIVE
CGTBiologicOno Pharmaceutical Co., Ltd.Phase 3

tegafur-gimeracil-oteracil potassium (tegafur-gimeracil-oteracil potassium)

Gastric Cancer · Colorectal Cancer

#ColorectalCancer#CGT#Phase3#인기#세포유전치료+5
임상시험 54상태 RECRUITING
CGTBiologicAlaunos TherapeuticsPreclinical

autologous activated T lymphocyte (autologous activated T lymphocyte)

Relapsed or Advanced Gastric Adenocarcinoma; Gastro-esophageal Junction Cancer · Relapsed or Advanced Gastric Adenocarcin

#RelapsedorAdvancedGastricAdenoca#CGT#Preclinical#인기#세포유전치료+5
임상시험 51상태 ACTIVE
ADCBiologicstaleAstraZenecaderuxtecan plus fluoropyrim…Phase 3

FLOT Chemotherapy (FLOT Chemotherapy)

Gastrointestinal Neoplasms; Esophagogastric Junction · Gastroesophageal Adenocarcinoma

#GastroesophagealAdenocarcinoma#ADC#Phase3#인기#항체약물접합체+5
임상시험 50상태 RECRUITING
ADCBiologicstaleShanghai Miracogen Inc.Phase 3

MRG003 (MRG003)

Squamous Cell Carcinoma of the Head and Neck · Advanced or Metastatic Gastric Cancer

#AdvancedorMetastaticGastricCance#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 30상태 ACTIVE
AntibodystaleAstraZenecaPhase 3

Ramucirumab+ paclitaxel (Ramucirumab+ paclitaxel)

Gastric Cancer; Gastroesophageal Junction Cancer · Gastric Cancer

#GastricCancer#Antibody#Phase3#항체#면역항체+3
효능 ORR 58.2%임상시험 30상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 3

Nemtabrutinib (Nemtabrutinib)

Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma; Gastric Mucosa-Associated Lymphoid Tissue Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 0.0%임상시험 23상태 RECRUITING
AntibodystaleAstraZenecaPhase 3

zolbetuximab (zolbetuximab)

Gastric Cancer; Gastroesophageal Junction Adenocarcinoma · Locally Advanced Unresectable Gastroesop

#LocallyAdvancedUnresectableGastr#Antibody#Phase3#항체#면역항체+4
효능 ORR 48.1%임상시험 23상태 RECRUITING
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 2

CEA-targeted CAR-T cells (CEA-targeted CAR-T cells)

Gastric Cancer; Colon Cancer · CEA

#CEA#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 19상태 ACTIVE
ADCBiologicstaleRemeGen Co., Ltd.Phase 3

disitamab vedotin (Disitamab Vedotin, RC48, RC48-ADC（2.0mg/kg）)

Gastric Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 19상태 RECRUITING
AntibodystaleNeovii BiotechPhase 2

Catumaxomab (Catumaxomab)

Gastric Cancer; Gastric Adenocarcinoma · Gastric Cancer

#GastricCancer#Antibody#Phase2#항체#면역항체+3
임상시험 18상태 ACTIVE
ADCBiologicstaleBoehringer IngelheimPhase 2

Zongertinib (Zongertinib)

Metastatic Breast Cancer; Metastatic Gastric Adenocarcinoma · Metastatic Breast Cancer

#MetastaticBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 15상태 RECRUITING
AntibodystaleAstraZenecaPhase 1

durvalumab (Imfinzi, Administration of ceralasertib and durvalumab)

Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer · Adv Solid Malig - H&N SCC, ATM Pro / Def

#AdvSolidMalig-HNSCCATMProDef#Antibody#Phase1#항체#면역항체+5
효능 ORR 9.5%임상시험 12상태 RECRUITING
ADCBiologicstaleK-Group, Beta, Inc., a wholly o…Phase 1

Azenosertib (Azenosertib)

Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 · Clinical Stage III Gastric Cancer AJCC v

#ClinicalStageIIIGastricCancerAJC#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 12상태 RECRUITING
ADCBiologicstaleRemeGenPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin Combined With Sintilimab)

Gastric Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 10상태 ACTIVE
ADCBiologicstaleCSPC ZhongQi Pharmaceutical Tec…Phase 3

DP303c (DP303c)

HER2-positive Breast Cancer · Localized Advanced or Metastatic Gastric

#LocalizedAdvancedorMetastaticGas#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 9상태 RECRUITING
ADCBiologicstaleRemeGen Co., Ltd.Phase 3

disitamab vedotin (Disitamab Vedotin, RC48, RC48-ADC（2.5mg/kg）)

Gastric Cancer · Gastric Cancer

#GastricCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 7상태 RECRUITING
ADCBiologicstaleAstraZenecaPhase 2

AZD0901 (AZD0901)

Gastric Cancer; Gastroesophageal Junction Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 6상태 RECRUITING
ADCBiologicstaleAstraZenecasPhase 3

Sonesitatug vedotin (Sonesitatug vedotin)

Gastric Cancer; Gastroesophageal Junction Adenocarcinoma · Gastric Cancer

#GastricCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
임상시험 6상태 RECRUITING

2 / 7 페이지

← 이전다음 →